Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on ...
As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...
Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...
Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for ...
KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results